Morning Overview on MSN
A new drug combo shrank treatment-resistant colon cancer in a large clinical trial
Patients with metastatic colorectal cancer that had stopped responding to at least two prior treatment regimens gained ...
Immunotherapy wipes out some colorectal tumors without surgery, signaling a major shift toward less invasive treatment.
Morning Overview on MSN
A colon cancer therapy shrank tumors so well that most patients showed no cancer before surgery
A short course of immunotherapy given before surgery eliminated detectable colon cancer in a majority of patients whose ...
A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer. The study, ...
Randomized data support structured post-adjuvant exercise as a disease-modifying survivorship strategy, improving disease-free survival and overall survival compared with education-only control.
Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. AbbVie is running a late-stage cancer study called “An Open-Label, Randomized, Controlled, Global ...
A first-of-its-kind trial platform in the colorectal cancer space, Project Cure CRC's KLEOS is being driven by the Colorectal Cancer Alliance, the leading nonprofit dedicated to ending the disease, in ...
The Korean Association for Cancer Chemotherapy Research (KCSG) unveiled the achievements of domestic multi-center clinical ...
Early in his career at Case Western Reserve University, Zhenghe “John” Wang, PhD, was teaching his students about colon cancer when he realized he was experiencing many of the same symptoms. A low ...
Dr. John Marshall explains why biomarker testing should be done early in colorectal cancer to guide treatment and identify targeted therapies. Biomarker testing is no longer optional in colorectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results